Zoledronic acid results in better health-related quality of life following hip fracture: the HORIZON-Recurrent Fracture Trial. uri icon

authors

  • Adachi, J D
  • Moore, K A
  • Bucci-Rechtweg, C
  • Su, G
  • Eriksen, E F
  • Magaziner, J S
  • Lyles, K W
  • Colón-Emeric, C S
  • Boonen, S
  • Pieper, C F
  • Mautalen, C
  • Hyldstrup, L
  • Recknor, C
  • Nordsletten, L

publication date

  • January 1, 2011